|
G |
ALDH1A2 |
aldehyde dehydrogenase 1 family member A2 |
decreases activity |
EXP |
Benzaldehydes results in decreased activity of ALDH1A2 protein |
CTD |
PMID:22079344 |
|
NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866
|
|
G |
ALDH2 |
aldehyde dehydrogenase 2 family member |
decreases activity |
EXP |
Benzaldehydes results in decreased activity of ALDH2 protein |
CTD |
PMID:22079344 |
|
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
|
|
|
G |
ALDH2 |
aldehyde dehydrogenase 2 family member |
increases metabolic processing |
EXP |
ALDH2 protein results in increased metabolism of 2,5-dihydroxybenzaldehyde |
CTD |
PMID:11744614 |
|
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
|
|
|
G |
AKR7A2 |
aldo-keto reductase family 7 member A2 |
increases reduction affects reduction |
EXP ISO |
AKR7A2 protein results in increased reduction of 2-nitrobenzaldehyde 2-nitrobenzaldehyde affects the reduction of AKR7A5 protein |
CTD |
PMID:10510318 PMID:12604212 |
|
NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144
|
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of ACHE protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of ACHE protein] |
CTD |
PMID:29665407 PMID:29732668 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] |
CTD |
PMID:25582705 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
multiple interactions |
EXP ISO |
protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of AGER protein] protocatechualdehyde inhibits the reaction [Bleomycin results in decreased expression of AGER protein] |
CTD |
PMID:17597607 PMID:25582705 |
|
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
CAT |
catalase |
multiple interactions increases activity |
EXP |
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] protocatechualdehyde results in increased activity of CAT protein |
CTD |
PMID:29665407 PMID:29732668 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CDH1 |
cadherin 1 |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein] |
CTD |
PMID:25582705 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
FGF2 |
fibroblast growth factor 2 |
multiple interactions |
EXP ISO |
protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of FGF2 protein] protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of FGF2 protein] |
CTD |
PMID:25582705 |
|
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of G6PD protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] |
CTD |
PMID:29665407 PMID:29732668 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GLO1 |
glyoxalase I |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [sodium arsenite results in increased activity of GLO1 protein] |
CTD |
PMID:29732668 |
|
NCBI chr 6:38,675,925...38,703,145
Ensembl chr 6:38,675,925...38,703,145
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of GSR protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of GSR protein] |
CTD |
PMID:29665407 PMID:29732668 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HMGB1 |
high mobility group box 1 |
multiple interactions |
ISO EXP |
protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of HMGB1 protein] protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of HMGB1 protein] |
CTD |
PMID:25582705 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
S100B |
S100 calcium binding protein B |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD2 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD3 protein] |
CTD |
PMID:17597607 |
|
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
|
|
G |
SMAD2 |
SMAD family member 2 |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD2 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD2 protein] |
CTD |
PMID:17597607 |
|
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
|
|
G |
SMAD3 |
SMAD family member 3 |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD3 protein] |
CTD |
PMID:17597607 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in increased activity of SOD1 protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of SOD1 protein] |
CTD |
PMID:29665407 PMID:29732668 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of AGER protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of FGF2 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of HMGB1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of VIM protein] |
CTD |
PMID:17597607 PMID:25582705 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
VIM |
vimentin |
multiple interactions |
EXP |
protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of VIM protein] |
CTD |
PMID:25582705 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
|
G |
AR |
androgen receptor |
multiple interactions |
EXP |
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of AR protein |
CTD |
PMID:27633901 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:27633901 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
multiple interactions |
EXP |
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of NR3C1 protein |
CTD |
PMID:27633901 |
|
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
|
|
G |
PGR |
progesterone receptor |
multiple interactions |
EXP |
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PGR protein |
CTD |
PMID:27633901 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
EXP |
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein |
CTD |
PMID:27633901 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
THRB |
thyroid hormone receptor beta |
multiple interactions |
EXP |
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of THRB protein |
CTD |
PMID:27633901 |
|
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
|
|
|
G |
ALDH2 |
aldehyde dehydrogenase 2 family member |
increases metabolic processing |
EXP |
ALDH2 protein results in increased metabolism of 3-hydroxybenzaldehyde |
CTD |
PMID:11744614 |
|
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
|
|
|
G |
ALDH1A1 |
aldehyde dehydrogenase 1 family member A1 |
decreases activity multiple interactions increases oxidation |
ISO EXP |
4-(diethylamino)benzaldehyde results in decreased activity of ALDH1A1 protein 4-(diethylamino)benzaldehyde inhibits the reaction [ALDH1A1 protein results in decreased susceptibility to mafosfamide] ALDH1A1 protein results in increased oxidation of 4-(diethylamino)benzaldehyde |
CTD |
PMID:8662658 PMID:16316642 PMID:25512087 |
|
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
|
|
G |
ALDH1A2 |
aldehyde dehydrogenase 1 family member A2 |
multiple interactions |
EXP |
4-(diethylamino)benzaldehyde binds to and results in decreased activity of ALDH1A2 protein |
CTD |
PMID:25512087 |
|
NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866
|
|
G |
ALDH2 |
aldehyde dehydrogenase 2 family member |
multiple interactions |
EXP |
4-(diethylamino)benzaldehyde binds to and results in decreased activity of ALDH2 protein |
CTD |
PMID:25512087 |
|
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
|
|
G |
ALDH3A1 |
aldehyde dehydrogenase 3 family member A1 |
increases oxidation |
EXP |
ALDH3A1 protein results in increased oxidation of 4-(diethylamino)benzaldehyde |
CTD |
PMID:25512087 |
|
NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943
|
|
|
G |
AKR1A1 |
aldo-keto reductase family 1 member A1 |
increases reduction |
EXP |
AKR1A1 protein results in increased reduction of 4-carboxybenzaladehyde |
CTD |
PMID:10510318 |
|
NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049
|
|
|
G |
AKR1A1 |
aldo-keto reductase family 1 member A1 |
increases reduction |
EXP |
AKR1A1 protein results in increased reduction of 4-nitrobenzaldehyde |
CTD |
PMID:10510318 |
|
NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049
|
|
G |
AKR1B1 |
aldo-keto reductase family 1 member B |
increases reduction |
EXP |
AKR1B1 protein results in increased reduction of 4-nitrobenzaldehyde |
CTD |
PMID:10510318 |
|
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
|
|
G |
AKR1B15 |
aldo-keto reductase family 1 member B15 |
increases metabolic processing |
EXP |
AKR1B15 protein results in increased metabolism of 4-nitrobenzaldehyde |
CTD |
PMID:21276782 |
|
NCBI chr 7:134,549,110...134,579,869
Ensembl chr 7:134,549,110...134,579,875
|
|
G |
AKR7A2 |
aldo-keto reductase family 7 member A2 |
multiple interactions affects reduction |
ISO |
Ethacrynic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Indomethacin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Quercetin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Valproic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein] |
CTD |
PMID:12604212 |
|
NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144
|
|
G |
DHRS7 |
dehydrogenase/reductase 7 |
increases reduction |
EXP |
DHRS7 protein results in increased reduction of 4-nitrobenzaldehyde |
CTD |
PMID:24246760 |
|
NCBI chr14:60,144,119...60,169,889
Ensembl chr14:60,144,119...60,169,856
|
|
G |
DYRK2 |
dual specificity tyrosine phosphorylation regulated kinase 2 |
multiple interactions |
EXP |
[Curcumin binds to 4-nitrobenzaldehyde] which results in decreased activity of DYRK2 protein |
CTD |
PMID:33617879 |
|
NCBI chr12:67,648,745...67,665,406
Ensembl chr12:67,648,338...67,665,406
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 4-nitrobenzaldehyde] |
CTD |
PMID:20932822 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
|
G |
ALDH1A1 |
aldehyde dehydrogenase 1 family member A1 |
increases oxidation increases metabolic processing |
ISO |
ALDH1A1 protein results in increased oxidation of benzaldehyde ALDH1A1 protein results in increased metabolism of benzaldehyde |
CTD |
PMID:10998257 PMID:21256123 |
|
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
|
|
G |
ALDH2 |
aldehyde dehydrogenase 2 family member |
increases metabolic processing multiple interactions |
EXP |
ALDH2 protein results in increased metabolism of benzaldehyde benzaldehyde inhibits the reaction [4-dimethylaminocinnamaldehyde binds to ALDH2 protein] |
CTD |
PMID:10609638 PMID:11744614 |
|
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
|
|
G |
ALDH3A1 |
aldehyde dehydrogenase 3 family member A1 |
multiple interactions increases oxidation increases metabolic processing |
EXP ISO |
[ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde; [ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde; Cimetidine inhibits the reaction [ALDH3A1 protein results in increased oxidation of benzaldehyde] ALDH3A1 protein results in increased metabolism of benzaldehyde |
CTD |
PMID:10856427 PMID:21256123 PMID:21349255 PMID:23220590 PMID:25512087 |
|
NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943
|
|
G |
ALDH3B1 |
aldehyde dehydrogenase 3 family member B1 |
affects binding |
EXP |
benzaldehyde binds to ALDH3B1 protein |
CTD |
PMID:20699116 |
|
NCBI chr11:68,008,547...68,029,276
Ensembl chr11:68,008,578...68,029,282
|
|
G |
AR |
androgen receptor |
multiple interactions |
ISO |
benzaldehyde inhibits the reaction [Metribolone binds to AR protein] |
CTD |
PMID:3695475 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
increases chemical synthesis decreases activity multiple interactions |
EXP |
CYP2A6 protein results in increased chemical synthesis of benzaldehyde benzaldehyde results in decreased activity of CYP2A6 protein [[benzaldehyde results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin; [benzaldehyde results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin |
CTD |
PMID:10616189 PMID:32496054 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
OR8A1 |
olfactory receptor family 8 subfamily A member 1 |
multiple interactions |
ISO |
benzaldehyde binds to and results in increased activity of OR8A1 protein |
CTD |
PMID:11943806 |
|
NCBI chr11:124,569,997...124,571,374
Ensembl chr11:124,566,660...124,582,942
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
increases activity multiple interactions |
ISO |
benzaldehyde results in increased activity of SLC2A1 protein [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein |
CTD |
PMID:20955755 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
multiple interactions decreases activity |
EXP |
[[ethyl vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin; [ethyl vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin |
CTD |
PMID:32496054 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
OR5D18 |
olfactory receptor family 5 subfamily D member 18 |
multiple interactions |
ISO |
[ethyl vanillin binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; ethyl vanillin binds to and results in increased activity of OR5D18 protein |
CTD |
PMID:15716417 |
|
NCBI chr11:55,819,630...55,820,571
Ensembl chr11:55,819,630...55,820,571
|
|
G |
TRPV3 |
transient receptor potential cation channel subfamily V member 3 |
increases activity |
ISO |
ethyl vanillin results in increased activity of TRPV3 protein |
CTD |
PMID:16617338 |
|
NCBI chr17:3,510,502...3,557,812
Ensembl chr17:3,510,502...3,557,812
|
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases activity |
ISO |
3-methylbenzaldehyde results in decreased activity of CYP2E1 protein |
CTD |
PMID:12791539 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP4B1 |
cytochrome P450 family 4 subfamily B member 1 |
affects activity |
ISO |
3-methylbenzaldehyde affects the activity of CYP4B1 protein |
CTD |
PMID:12791539 |
|
NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413
|
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases glucuronidation |
EXP |
UGT1A10 protein results in increased glucuronidation of 2-vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A3 |
UDP glucuronosyltransferase family 1 member A3 |
increases glucuronidation |
EXP |
UGT1A3 protein results in increased glucuronidation of 2-vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
|
|
G |
UGT1A7 |
UDP glucuronosyltransferase family 1 member A7 |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of 2-vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
|
|
G |
UGT1A8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
EXP |
UGT1A8 protein results in increased glucuronidation of 2-vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
|
|
|
G |
TRPA1 |
transient receptor potential cation channel subfamily A member 1 |
increases activity |
EXP |
4-anisaldehyde results in increased activity of TRPA1 protein |
CTD |
PMID:21591660 |
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
|
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
4-methylbenzaldehyde binds to and results in decreased activity of AHR protein |
CTD |
PMID:27633901 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AR |
androgen receptor |
multiple interactions |
EXP |
4-methylbenzaldehyde binds to and results in decreased activity of AR protein |
CTD |
PMID:27633901 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ESR2 |
estrogen receptor 2 |
multiple interactions |
EXP |
4-methylbenzaldehyde binds to and results in decreased activity of ESR2 protein |
CTD |
PMID:27633901 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IL1B protein] |
CTD |
PMID:27569861 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:27569861 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:27569861 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:27569861 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] |
CTD |
PMID:27569861 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:27569861 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:27569861 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PGR |
progesterone receptor |
multiple interactions |
EXP |
4-methylbenzaldehyde binds to and results in decreased activity of PGR protein |
CTD |
PMID:27633901 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
EXP |
4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein |
CTD |
PMID:27633901 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:27569861 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:27569861 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:27569861 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
AICDA |
activation induced cytidine deaminase |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of AICDA mRNA |
CTD |
PMID:22302311 |
|
NCBI chr12:8,602,170...8,612,859
Ensembl chr12:8,602,155...8,613,242
|
|
G |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of AKR1C18 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
|
|
G |
CCL15 |
C-C motif chemokine ligand 15 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CCL6 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553
|
|
G |
CCNA2 |
cyclin A2 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CCNA2 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CCNB1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCNE2 |
cyclin E2 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CCNE2 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
|
|
G |
CCR4 |
C-C motif chemokine receptor 4 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CCR4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349
|
|
G |
CD207 |
CD207 molecule |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CD207 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 2:70,824,130...70,835,816
Ensembl chr 2:70,830,211...70,835,816
|
|
G |
CD5L |
CD5 molecule like |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CD5L mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 1:157,827,068...157,841,808
Ensembl chr 1:157,830,911...157,898,256
|
|
G |
CD83 |
CD83 molecule |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CD83 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,136,918
|
|
G |
CDC20 |
cell division cycle 20 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CDC20 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
|
|
G |
CDC25C |
cell division cycle 25C |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CDC25C mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CDK1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CLEC7A |
C-type lectin domain containing 7A |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CLEC7A mRNA |
CTD |
PMID:22302311 |
|
NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
|
|
G |
COL8A1 |
collagen type VIII alpha 1 chain |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of COL8A1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 3:99,638,594...99,799,217
Ensembl chr 3:99,638,475...99,799,226
|
|
G |
CPHXL2 |
cytoplasmic polyadenylated homeobox like 2 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CPHX1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr16:75,660,227...75,677,009
Ensembl chr16:75,660,227...75,677,009 Ensembl chr16:75,660,227...75,677,009
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of CTLA4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
decreases expression |
ISO |
o-Phthalaldehyde results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20112102 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases expression |
ISO |
o-Phthalaldehyde results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:20112102 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
DIO1 |
iodothyronine deiodinase 1 |
decreases activity |
EXP |
o-Phthalaldehyde results in decreased activity of DIO1 protein |
CTD |
PMID:30561685 |
|
NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086
|
|
G |
DIO2 |
iodothyronine deiodinase 2 |
decreases activity |
EXP |
o-Phthalaldehyde results in decreased activity of DIO2 protein |
CTD |
PMID:30561685 |
|
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
|
|
G |
DIO3 |
iodothyronine deiodinase 3 |
decreases activity |
EXP |
o-Phthalaldehyde results in decreased activity of DIO3 protein |
CTD |
PMID:30561685 |
|
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
|
|
G |
E2F1 |
E2F transcription factor 1 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of E2F1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
|
|
G |
FABP7 |
fatty acid binding protein 7 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of FABP7 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 6:122,749,201...122,784,074
Ensembl chr 6:122,779,716...122,784,074
|
|
G |
FXYD4 |
FXYD domain containing ion transport regulator 4 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of FXYD4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:43,371,636...43,376,335
Ensembl chr10:43,371,636...43,376,335
|
|
G |
GZMB |
granzyme B |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of GZMB mRNA |
CTD |
PMID:22302311 |
|
NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267
|
|
G |
IFNG |
interferon gamma |
increases expression |
ISO |
o-Phthalaldehyde results in increased expression of IFNG mRNA |
CTD |
PMID:21785612 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
increases expression |
ISO |
o-Phthalaldehyde results in increased expression of IL10 mRNA |
CTD |
PMID:21785612 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12B |
interleukin 12B |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of IL12B mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL13 |
interleukin 13 |
increases expression |
ISO |
o-Phthalaldehyde results in increased expression of IL13 mRNA |
CTD |
PMID:21785612 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL1B |
interleukin 1 beta |
increases expression |
ISO |
o-Phthalaldehyde results in increased expression of IL1B mRNA |
CTD |
PMID:21785612 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL21 |
interleukin 21 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of IL21 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
|
|
G |
IL2RA |
interleukin 2 receptor subunit alpha |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of IL2RA mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
|
|
G |
IL4 |
interleukin 4 |
affects expression increases expression |
ISO |
o-Phthalaldehyde affects the expression of IL4 mRNA o-Phthalaldehyde results in increased expression of IL4 mRNA; o-Phthalaldehyde results in increased expression of IL4 protein |
CTD |
PMID:19110043 PMID:20176622 PMID:21785612 PMID:22302311 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
increases expression |
ISO |
o-Phthalaldehyde results in increased expression of IL5 mRNA |
CTD |
PMID:19110043 PMID:21785612 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
ITGAV |
integrin subunit alpha V |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of ITGAV mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
|
|
G |
IYD |
iodotyrosine deiodinase |
multiple interactions |
EXP |
o-Phthalaldehyde inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969
|
|
G |
LGALS7 |
galectin 7 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of LGALS7 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr19:38,770,968...38,773,517
Ensembl chr19:38,789,200...38,791,754 Ensembl chr19:38,789,200...38,791,754
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of MKI67 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
NTS |
neurotensin |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of NTS mRNA |
CTD |
PMID:22302311 |
|
NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992
|
|
G |
THBS1 |
thrombospondin 1 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of THBS1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
|
|
G |
THBS4 |
thrombospondin 4 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of THBS4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:79,991,332...80,083,287
Ensembl chr 5:79,991,311...80,083,287
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of TIMP1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TNF |
tumor necrosis factor |
increases expression |
ISO |
o-Phthalaldehyde results in increased expression of TNF mRNA |
CTD |
PMID:21785612 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
affects activity |
EXP |
o-Phthalaldehyde affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TRPM6 |
transient receptor potential cation channel subfamily M member 6 |
affects expression |
ISO |
o-Phthalaldehyde affects the expression of TRPM6 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 9:74,722,495...74,887,921
Ensembl chr 9:74,722,495...74,888,094
|
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions |
ISO |
vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in increased expression of ACHE protein] |
CTD |
PMID:33823243 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
increases expression |
EXP |
vanillin results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
CA1 |
carbonic anhydrase 1 |
decreases activity |
EXP |
vanillin results in decreased activity of CA1 protein |
CTD |
PMID:19231207 |
|
NCBI chr 8:85,327,608...85,378,113
Ensembl chr 8:85,327,608...85,379,014
|
|
G |
CA2 |
carbonic anhydrase 2 |
decreases activity |
EXP |
vanillin results in decreased activity of CA2 protein |
CTD |
PMID:19231207 |
|
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO |
vanillin inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; vanillin inhibits the reaction [Methotrexate results in increased activity of CASP3 protein] |
CTD |
PMID:29216766 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
multiple interactions |
ISO EXP |
vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein] vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in decreased activity of CAT protein] |
CTD |
PMID:26296324 PMID:33823243 PMID:37336463 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein] |
CTD |
PMID:36416909 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCN2 |
cellular communication network factor 2 |
decreases expression |
EXP |
vanillin results in decreased expression of CCN2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CLK2 |
CDC like kinase 2 |
increases expression |
EXP |
vanillin results in increased expression of CLK2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 1:155,262,868...155,273,504
Ensembl chr 1:155,262,868...155,278,491
|
|
G |
CST3 |
cystatin C |
multiple interactions |
ISO |
vanillin inhibits the reaction [Cisplatin results in increased expression of CST3 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of CST3 protein] |
CTD |
PMID:29216766 |
|
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression multiple interactions |
EXP |
vanillin results in increased expression of CXCL8 mRNA vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein] |
CTD |
PMID:20491607 PMID:21920952 PMID:36416909 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression |
EXP |
vanillin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
multiple interactions decreases activity |
EXP |
[[vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin; [vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin |
CTD |
PMID:32496054 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
increases expression |
EXP |
vanillin results in increased expression of DDIT4 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
decreases expression |
EXP |
vanillin results in decreased expression of DNMT3B mRNA |
CTD |
PMID:17178418 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
DUSP6 |
dual specificity phosphatase 6 |
decreases expression |
EXP |
vanillin results in decreased expression of DUSP6 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
|
|
G |
FASLG |
Fas ligand |
multiple interactions |
ISO |
vanillin inhibits the reaction [Cisplatin results in increased expression of FASLG protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of FASLG protein] |
CTD |
PMID:29216766 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FBP1 |
fructose-bisphosphatase 1 |
affects binding |
EXP |
vanillin binds to FBP1 protein |
CTD |
PMID:33823243 |
|
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
|
|
G |
FGFR2 |
fibroblast growth factor receptor 2 |
decreases expression |
EXP |
vanillin results in decreased expression of FGFR2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
|
|
G |
FZD2 |
frizzled class receptor 2 |
decreases expression |
EXP |
vanillin results in decreased expression of FZD2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262
|
|
G |
G6PC1 |
glucose-6-phosphatase catalytic subunit 1 |
affects binding |
EXP |
vanillin binds to G6PC1 protein |
CTD |
PMID:33823243 |
|
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] |
CTD |
PMID:37336463 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
multiple interactions |
EXP |
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GAPDH protein] |
CTD |
PMID:37336463 |
|
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression |
EXP |
vanillin results in increased expression of GCLC mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression |
EXP |
vanillin results in increased expression of GCLM mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GLO1 |
glyoxalase I |
multiple interactions |
EXP |
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GLO1 protein] |
CTD |
PMID:37336463 |
|
NCBI chr 6:38,675,925...38,703,145
Ensembl chr 6:38,675,925...38,703,145
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
EXP |
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein] |
CTD |
PMID:37336463 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
EXP |
vanillin results in increased expression of HMOX1 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
decreases mutagenesis |
EXP |
vanillin results in decreased mutagenesis of HPRT1 gene |
CTD |
PMID:17178418 |
|
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
increases expression |
EXP |
vanillin results in increased expression of HSPA1B mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
IL12B |
interleukin 12B |
multiple interactions |
EXP |
vanillin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein] |
CTD |
PMID:36416909 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
ISO |
vanillin inhibits the reaction [Cisplatin results in increased expression of IL18 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of IL18 protein] |
CTD |
PMID:29216766 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INSIG1 |
insulin induced gene 1 |
decreases expression |
EXP |
vanillin results in decreased expression of INSIG1 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
|
|
G |
JUND |
JunD proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
vanillin results in decreased expression of JUND mRNA |
CTD |
PMID:17178418 |
|
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
|
|
G |
LCN2 |
lipocalin 2 |
multiple interactions |
ISO |
vanillin inhibits the reaction [Cisplatin results in increased expression of LCN2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein] |
CTD |
PMID:29216766 |
|
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
|
|
G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
decreases expression |
EXP |
vanillin results in decreased expression of MAP2K2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
|
|
G |
MARK4 |
microtubule affinity regulating kinase 4 |
decreases expression |
EXP |
vanillin results in decreased expression of MARK4 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr19:45,251,271...45,305,284
Ensembl chr19:45,079,288...45,305,284
|
|
G |
MT1X |
metallothionein 1X |
multiple interactions |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
increases expression multiple interactions |
EXP ISO |
vanillin results in increased expression of MT2A mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA] |
CTD |
PMID:20491607 PMID:27074584 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
vanillin inhibits the reaction [Cisplatin results in increased expression of NOS2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of NOS2 protein] |
CTD |
PMID:29216766 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PPP1R10 |
protein phosphatase 1 regulatory subunit 10 |
decreases expression |
EXP |
vanillin results in decreased expression of PPP1R10 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 6:30,600,413...30,617,243
Ensembl chr 6:30,600,413...30,618,612
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
vanillin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA] |
CTD |
PMID:17465205 PMID:26296324 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PYGL |
glycogen phosphorylase L |
affects binding |
EXP |
vanillin binds to PYGL protein |
CTD |
PMID:33823243 |
|
NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
vanillin inhibits the reaction [Cisplatin results in increased expression of RELA protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of RELA protein] |
CTD |
PMID:29216766 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SLC35D2 |
solute carrier family 35 member D2 |
decreases expression |
EXP |
vanillin results in decreased expression of SLC35D2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 9:96,313,444...96,383,711
Ensembl chr 9:96,313,444...96,383,711
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
increases expression |
EXP |
vanillin results in increased expression of SLC7A11 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
decreases expression |
EXP |
vanillin results in decreased expression of TGFB1I1 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr16:31,472,152...31,477,960
Ensembl chr16:31,471,585...31,477,960
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein] vanillin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of TNF protein] |
CTD |
PMID:26296324 PMID:29216766 PMID:36416909 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
decreases expression |
EXP |
vanillin results in decreased expression of TP53 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TRIM16 |
tripartite motif containing 16 |
increases expression |
EXP |
vanillin results in increased expression of TRIM16 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311
|
|
G |
TRPV3 |
transient receptor potential cation channel subfamily V member 3 |
increases activity |
ISO |
vanillin results in increased activity of TRPV3 protein |
CTD |
PMID:16617338 |
|
NCBI chr17:3,510,502...3,557,812
Ensembl chr17:3,510,502...3,557,812
|
|
G |
UGP2 |
UDP-glucose pyrophosphorylase 2 |
increases expression |
EXP |
vanillin results in increased expression of UGP2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 2:63,840,969...63,891,560
Ensembl chr 2:63,840,952...63,891,562
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases glucuronidation |
EXP |
UGT1A10 protein results in increased glucuronidation of vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A3 |
UDP glucuronosyltransferase family 1 member A3 |
increases glucuronidation |
EXP |
UGT1A3 protein results in increased glucuronidation of vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
|
|
G |
UGT1A7 |
UDP glucuronosyltransferase family 1 member A7 |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
|
|
G |
UGT1A8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
EXP |
UGT1A8 protein results in increased glucuronidation of vanillin |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
|
|